CS Paper Radar

Decoupling Parcellation from Classification: Systematic Benchmark of Fast Brain Segmentation Methods for Alzheimer's Disease Detection

Jiadao Zou, Hongyu Guo, Wei Xi

eess.IV cs.AIcs.CV ·submitted 2026-08-17 03:08 UTC · v1
benchmark

Abstract

Brain parcellation and classification are typically evaluated in isolation, yet downstream AD detection performance depends on their interaction. We decouple these components and systematically benchmark fast deep learning parcellation methods (SynthSeg+, OpenMAP-T1) against the FreeSurfer (FS-HV) clinical baseline through down- stream AD classification on OASIS-1. Our factorial design evaluates three parcellation methods, two volumetry strategies (hard vs. soft), and four classifier paradigms (clinical thresholds, supervised feedforward networks, ensemble methods, and foundation models with zero/few-shot prompting), with all results quantified using BCa Bootstrap 95% confidence intervals.

Closest papers

Nearest neighbours by meaning across the whole index.

Anatomical Grounding and Leakage-Aware Multimodal Contrastive Learning for Alzheimer's Disease Classification from Structural MRI

cs.CV cs.AI ·2026-09-14 ·Paul-Gabriel Nicolae, Irina Georgiana Mocanu
theory similarity 0.72
Abstract · 13 pages, 4 figures

Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irrelevant regions, and multimodal models that add clinical tables frequently rely on variables that were used to assign the diagnostic label in the first place. We study both issues with a deliberately lightweight slice-based encoder (ResNet18 with a one-layer Transformer over slices) on 1,075 baseline T1-weighted scans from ADNI-1. First, we use FastSurfer segmentations as an anatomical reference: YOLOv8 models trained on segmentation-derived labels localize Alzheimer-relevant structures with mAP_50 above 0.96, and a Grad-CAM comparison shows that the image-only classifier frequently attends to the skull, orbits and background. Second, we adapt a CLIP-style image - tabular contrastive framework and organize ADNIMERGE variables along a label-leakage spectrum. Fusion with cognitive scores yields 87.3% three-way accuracy, which we treat as a leakage-driven upper bound rather than an imaging result; fusion with regional volumes yields 73.0%. We observe that the choice of contrastive target changes what the image encoder learns: on MCI vs. CN, the image-only head reaches 52.4% when the encoder is aligned to cognitive scores and 73.8\% when aligned to volumes, although no tabular input is used at inference. Third, restricting the input to a per-subject crop of the medial temporal lobe raises image-only three-way accuracy from 58.7% to 65.1%. All results come from single runs on a small balanced test set, and we report confidence intervals and the protocol differences that prevent direct comparison with published numbers.

0.16

Evidence Before Accuracy: A MRI-PET Fusion Network for Alzheimer Disease Classification with Causal Regional Validation

cs.CV ·2026-09-28 ·Saeid Firouzi Daghigh, Saeed Ayat
similarity 0.63
Abstract

Deep learning models for Alzheimer disease (AD) classification routinely report near-perfect discrimination, yet few are shown to rest on AD-relevant neurobiology rather than on dataset artifacts, subject-level leakage, or non-brain image content. We present a fusion network combining T1 MRI and FDG PET across axial, coronal, and sagittal planes, trained on ADNI consists of 554 paired subjects. The fusion model reaches AUC 0.962, accuracy 0.909, and F1 0.891, competitive with recent 3D CNN and multimodal transformer systems at substantially lower cost. We first quantify how much modality, plane and slice geometry matter. A validation-only search over slice centres and neighbour spacings moves AUC by 0.180 for MRI and 0.078 for PET, selecting narrow spacing for MRI and wide spacing for PET, with the chosen coronal centres falling on the hippocampal body and on the posterior cingulate respectively. The contribution, however, is the evidence layer built around that number. Shortcut controls collapse the model to AUC 0.622 (silhouette), 0.608 (exterior), and 0.500 (blank), and a label-permutation null yields 0.456. Forward region-of-interest (ROI) ablation shows that masking medial temporal cortex in MRI and the posterior default-mode network (DMN) in PET produces the largest shift in the AD logit, while area-matched controls remain indistinguishable from that null. Reverse ROI ablation shows that the medial temporal lobe alone retains 89.2% of above-chance discrimination in MRI and the posterior DMN alone retains 79.0% in PET. A quantitative comparison of attribution methods shows occlusion sensitivity reaching 3.5-5.0* enrichment inside a priori AD regions against 0.10-0.43* in controls. Ablation and attribution independently establish a biologically correct double dissociation: hippocampal evidence is carried by MRI, posterior cingulate evidence by PET.

0.12

AG-JEPA: Anatomically Guided Joint Embedding Predictive Architecture for Neurodegenerative Representation Learning

cs.CV cs.AI ·2026-11-13 ·Azad Singh, Ayantika Das, Amog Rao, Aiman Farooq, Anirban Porya +5 more
similarity 0.63
Abstract

Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent. However, during the transition from cognitively normal (CN) to mild cognitive impairment (MCI), the disease-related signals are often subtle and confined to only a few brain regions. Existing Joint Embedding Predictive Architecture (JEPA) models learn general structural representations but do not explicitly capture the anatomical regions affected in AD. We propose Anatomically Guided JEPA (AG-JEPA), which introduces anatomical tokens that interact with patch tokens during pretraining to learn region-specific representations from brain regions relevant to neurodegeneration. Building on this representation space, we further propose Prog-AG-JEPA, which models disease progression trajectory as a conditioned latent displacement within this space. We evaluate AG-JEPA across five downstream tasks spanning Alzheimer's disease diagnosis and progression prediction. AG-JEPA improves diagnosis and MCI prognosis, achieving an 8.4 percentage point AUROC gain over the strongest baseline on CN/MCI classification and a 7.1 percentage point gain on out-of-distribution CN/AD classification on the MR-RATE dataset, highlighting its effectiveness across both early-stage detection and cross-cohort generalization. For disease progression modeling, Prog-AG-JEPA consistently outperforms all baselines on future diagnosis and brain volume change prediction, demonstrating the value of anatomically grounded neurodegeneration representations for diagnosis and prognosis.

0.09

Improving the Clinical Generalizability of Machine Learning-Based Alzheimer's Disease Detection Across Domains and Modalities: A Comprehensive Review

eess.AS ·2026-11-05 ·Yingchao Huang, Yuhan Su, Xin Wang, Shanshan Yao
published similarity 0.63
Abstract · This paper has been accepted by the Journal of Alzheimer's Disease

Objective: This review aims to provide a comprehensive synthesis of domain adaptation (DA) and domain general- ization (DG) strategies for AD detection. It focuses on their potential to improve the robustness, generalizability, and clinical reliability of ML-based diagnostic systems. Methods: We conduct a comprehensive scoping review of existing DA and DG approaches across multiple data modalities. The reviewed studies are organized according to data modality, algorithmic framework, adaptation strat- egy, clinical relevance, and reported cross-domain performance. Key methodological trends, performance gains, limitations, and remaining challenges are analyzed to identify future research directions. Results: DA and DG approaches have demonstrated encouraging improvements in cross-domain performance and model robustness. Emerging modalities, such as speech-based approaches, EEG and eye-tracking data, show great po- tential for early, accessible, and non-invasive cognitive assessments. However, important limitations remain, including insufficient external validation, limited interpretability, computational complexity, privacy concerns, and challenges in scaling to routine clinical practice. Conclusion: DA and DG provide important methodological pathways for developing more generalizable ML-based systems for AD detection. Future research should prioritize explainable, computationally efficient, privacy-preserving, and clinically validated DA/DG techniques. Strengthening these aspects will be essential for translating robust AI- based AD detection tools into clinically deployable solutions.

0.22

HybridDualPathNet: Cross-Fusion Attention of EfficientNetV2 and Swin Transformer for Brain MRI Classification of Alzheimer's and Parkinson's Disease

cs.CV cs.LGcs.SE ·2026-10-12 ·Jarpula Nirjala, Rahul Patel
similarity 0.63
Abstract · Two experimental settings: Kaggle-only image-level evaluation and combined Kaggle and ADNI evaluation with patient-wise separation for ADNI …

Separating Alzheimer's Disease (AD), Parkinson's Disease (PD), and Healthy Controls (HC) using structural MRI remains challenging because disease signatures overlap and model performance can be strongly affected by data partitioning. We present HybridDualPathNet, a hybrid architecture combining EfficientNetV2-S for local features and Swin-Tiny for global context through a Cross-Fusion Attention (CFA) module. We evaluate the model in two experiments. First, on the Kaggle APD-3-Class dataset using an image-level split, the model achieves 98.25% accuracy. Second, on a combined Kaggle and Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset containing 17,859 slices, we use a per-source split with patient-wise separation for ADNI subjects. In this setting, the model achieves 73.37% standard accuracy and a macro AUC of 0.880. Source-stratified evaluation reveals a substantial domain gap, with 91.2% accuracy on Kaggle test images and 59.2% on ADNI test images. Temperature scaling reduces expected calibration error from 0.130 to 0.015, while split-conformal prediction achieves 89.5% coverage. Saliency analyses using Grad-CAM++, Integrated Gradients, and occlusion indicate that model activations concentrate on brain tissue. These results highlight the importance of patient-level separation, cross-dataset evaluation, and uncertainty estimation when assessing MRI classification systems. The findings also show that strong performance on a single dataset does not necessarily translate to reliable generalization across imaging cohorts.

0.13

Leveraging a Foundation Model for the EEG-Based Diagnosis of Alzheimer's Disease

cs.LG q-bio.NC ·2026-08-27 ·Maggie Lin, Chung-Lin Hou, Tzyy-Ping Jung
published similarity 0.62
Abstract · 7 pages, 9 figures, 1 table. Accepted and presented at the 48th Annual International Conference of the IEEE Engineering in Medicine and Biol…

Biological heterogeneity in Alzheimer's Disease (AD) poses a critical diagnostic challenge, particularly for traditional linear methods that fail to capture non-linear neural dynamics. To address this, we propose a diagnostic framework utilizing the Large Brain Model (LaBraM), pretrained on over 2,500 hours of EEG data. By integrating these high-dimensional latent embeddings with a non-linear Random Forest classifier, our approach effectively isolates robust disease markers. Under a rigorous subject-independent 5-fold cross-validation protocol, the method achieves an ROC-AUC of 89.36% +/- 3.49%, PR AUC of 81.45% +/- 4.43%, and Balanced Accuracy of 82.44% +/- 4.34% in distinguishing dementia patients from healthy controls. Notably, this performance uses only 8-second EEG segments, surpassing traditional spectral baselines, including band-power and parameterized oscillatory features (FOOOF). Post-hoc occlusion analysis confirms the model captures clinically validated biomarkers, specifically occipital-frontal Alpha and Theta rhythm degradation. Additional neurophysiological alignment analysis demonstrated that higher LaBraM-predicted dementia probability significantly correlated with worse cognitive performance, greater clinical severity, increased theta and alpha relative power, and higher aperiodic exponent. These findings demonstrate that deep latent representations extract clinically relevant signatures from noisy signals, enabling precise, rapid, and data-efficient diagnosis.

0.30

Emergence of Transfer Learning towards Specific Identification of Alzheimer's Disease A Prospective Approach

cs.CV cs.DL ·2026-08-13 ·Soumik Podder, Chandramouli Haldar
published similarity 0.62
Abstract

Worldwide, millions of senior citizens are suffering from Alzheimer disease abbreviated as AD, a well- versed form of dementia. AD is featured by amnesia, intellectual disability, and difficulty with consciousness. DL and ML models are undoubtedly explored to identify AD related patterns on large dimensional neuroimaging data but they need global optimization and are suffering from overfitting issue that might yield dissatisfactory result in testing data set. DL overcomes the issue by convolution of input image with kernel but any sudden change in the MRI image or human manipulation, limited pre- processing of the images can mislead CNN in achieving highly accurate detection. Transfer Learning (TL) has proved itself in AD diagnosis by utilizing pre-trained models on large data sets to guide novice model in a new neuroimaging dataset. This review provides an inclusive glimpse of TL implication in classification, identification including the conversion of AD. Keeping in view, we have assessed the strengths and limitations of TL in improvising diagnostic accuracy even with limited data. The uniqueness of the present review is the incorporation of explainable AI in TL based AD diagnosis system. Finally, it can be claimed that the review will guide the new re-searchers in the area of TL induced neurodegenerative disease detection.

0.58

Evaluating the Generalization of Neuroimaging Foundation Models on African Brain MRI

cs.CV ·2026-09-21 ·Oluwatobi Iyanuoluwa Akinmuleya, Olatokun Shamsudeen Akano, Samuel Danquah Ankapong, Olamide Lawal, Toufiq Musah
published similarity 0.61
Abstract · MICCAI AFRICAI Workshop, Strasbourg, France, 2026, 10 Pages, 1 Figure, 2 Tables

Neuroimaging foundation models pretrained on large, predominantly western cohorts are increasingly proposed as general-purpose backbones for brain MRI analysis. Yet, their ability to generalize to underrepresented clinical populations remains largely untested. We evaluate four recent foundation models (BrainIAC, Neuro-JEPA, NeuroVFM, and Primus) on a three-way diagnostic classification task (Control, Dementia, Parkinson's disease) using a cohort of 88 subjects from a Nigerian clinical brain MRI dataset, across four modality configurations (T1w, T2w, T1w+T2w, FLAIR), and compare against an end-to-end trained ViT3D baseline. The frozen backbones collapse to majority-class predictions, while Neuro-JEPA on FLAIR shows modest but still limited discrimination. In contrast, the end-to-end trained ViT3D achieves higher accuracy and MCC on every task (up to 53.4% accuracy, MCC=0.27) and is the only model with non-trivial recall. Our findings suggest that these frozen neuroimaging foundation models are insufficient for fine-grained diagnostic classification in small, non-western clinical cohorts, motivating parameter-efficient adaptation and broader multi-site external validation for equitable deployment in global health settings.

0.29